248 related articles for article (PubMed ID: 25451714)
1. 16p11.2 de novo microdeletion encompassing SRCAP gene in a patient with speech impairment, global developmental delay and behavioural problems.
Gerundino F; Marseglia G; Pescucci C; Pelo E; Benelli M; Giachini C; Federighi B; Antonelli C; Torricelli F
Eur J Med Genet; 2014; 57(11-12):649-53. PubMed ID: 25451714
[TBL] [Abstract][Full Text] [Related]
2. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.
Shinawi M; Liu P; Kang SH; Shen J; Belmont JW; Scott DA; Probst FJ; Craigen WJ; Graham BH; Pursley A; Clark G; Lee J; Proud M; Stocco A; Rodriguez DL; Kozel BA; Sparagana S; Roeder ER; McGrew SG; Kurczynski TW; Allison LJ; Amato S; Savage S; Patel A; Stankiewicz P; Beaudet AL; Cheung SW; Lupski JR
J Med Genet; 2010 May; 47(5):332-41. PubMed ID: 19914906
[TBL] [Abstract][Full Text] [Related]
3. Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome.
Seifert W; Meinecke P; Krüger G; Rossier E; Heinritz W; Wüsthof A; Horn D
BMC Med Genet; 2014 Nov; 15():127. PubMed ID: 25433523
[TBL] [Abstract][Full Text] [Related]
4. Not all floating-harbor syndrome cases are due to mutations in exon 34 of SRCAP.
Le Goff C; Mahaut C; Bottani A; Doray B; Goldenberg A; Moncla A; Odent S; Nitschke P; Munnich A; Faivre L; Cormier-Daire V
Hum Mutat; 2013 Jan; 34(1):88-92. PubMed ID: 22965468
[TBL] [Abstract][Full Text] [Related]
5. Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome.
Hood RL; Lines MA; Nikkel SM; Schwartzentruber J; Beaulieu C; Nowaczyk MJ; Allanson J; Kim CA; Wieczorek D; Moilanen JS; Lacombe D; Gillessen-Kaesbach G; Whiteford ML; Quaio CR; Gomy I; Bertola DR; Albrecht B; Platzer K; McGillivray G; Zou R; McLeod DR; Chudley AE; Chodirker BN; Marcadier J; ; Majewski J; Bulman DE; White SM; Boycott KM
Am J Hum Genet; 2012 Feb; 90(2):308-13. PubMed ID: 22265015
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of CMIP in a girl with autism spectrum disorder and developmental delay due to a de novo deletion on chromosome 16q23.2.
Van der Aa N; Vandeweyer G; Reyniers E; Kenis S; Dom L; Mortier G; Rooms L; Kooy RF
Autism Res; 2012 Aug; 5(4):277-81. PubMed ID: 22689534
[TBL] [Abstract][Full Text] [Related]
7. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
8. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
[TBL] [Abstract][Full Text] [Related]
9. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature.
Rots D; Chater-Diehl E; Dingemans AJM; Goodman SJ; Siu MT; Cytrynbaum C; Choufani S; Hoang N; Walker S; Awamleh Z; Charkow J; Meyn S; Pfundt R; Rinne T; Gardeitchik T; de Vries BBA; Deden AC; Leenders E; Kwint M; Stumpel CTRM; Stevens SJC; Vermeulen JR; van Harssel JVT; Bosch DGM; van Gassen KLI; van Binsbergen E; de Geus CM; Brackel H; Hempel M; Lessel D; Denecke J; Slavotinek A; Strober J; Crunk A; Folk L; Wentzensen IM; Yang H; Zou F; Millan F; Person R; Xie Y; Liu S; Ousager LB; Larsen M; Schultz-Rogers L; Morava E; Klee EW; Berry IR; Campbell J; Lindstrom K; Pruniski B; Neumeyer AM; Radley JA; Phornphutkul C; Schmidt B; Wilson WG; Õunap K; Reinson K; Pajusalu S; van Haeringen A; Ruivenkamp C; Cuperus R; Santos-Simarro F; Palomares-Bralo M; Pacio-Míguez M; Ritter A; Bhoj E; Tønne E; Tveten K; Cappuccio G; Brunetti-Pierri N; Rowe L; Bunn J; Saenz M; Platzer K; Mertens M; Caluseriu O; Nowaczyk MJM; Cohn RD; Kannu P; Alkhunaizi E; Chitayat D; Scherer SW; Brunner HG; Vissers LELM; Kleefstra T; Koolen DA; Weksberg R
Am J Hum Genet; 2021 Jun; 108(6):1053-1068. PubMed ID: 33909990
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up study for a patient with Floating-Harbor syndrome due to a hotspot SRCAP mutation.
Nagasaki K; Asami T; Sato H; Ogawa Y; Kikuchi T; Saitoh A; Ogata T; Fukami M
Am J Med Genet A; 2014 Mar; 164A(3):731-5. PubMed ID: 24375913
[TBL] [Abstract][Full Text] [Related]
11. 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment.
Marseglia G; Scordo MR; Pescucci C; Nannetti G; Biagini E; Scandurra V; Gerundino F; Magi A; Benelli M; Torricelli F
Eur J Med Genet; 2012 Mar; 55(3):216-21. PubMed ID: 22333924
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of DISP1 haploinsufficiency: A case report.
Jun KR; Hur YJ; Lee JN; Kim HR; Shin JH; Oh SH; Lee JY; Seo EJ
Eur J Med Genet; 2013 Jun; 56(6):309-13. PubMed ID: 23542665
[TBL] [Abstract][Full Text] [Related]
13. Perthes disease: A new finding in Floating-Harbor syndrome.
Milani D; Scuvera G; Gatti M; Tolva G; Bonarrigo F; Esposito S; Gervasini C
Am J Med Genet A; 2018 Mar; 176(3):703-706. PubMed ID: 29383823
[TBL] [Abstract][Full Text] [Related]
14. Microdeletion syndrome 16p11.2-p12.2: clinical and molecular characterization.
Hempel M; Rivera Brugués N; Wagenstaller J; Lederer G; Weitensteiner A; Seidel H; Meitinger T; Strom TM
Am J Med Genet A; 2009 Oct; 149A(10):2106-12. PubMed ID: 19676056
[TBL] [Abstract][Full Text] [Related]
15. The defining DNA methylation signature of Floating-Harbor Syndrome.
Hood RL; Schenkel LC; Nikkel SM; Ainsworth PJ; Pare G; Boycott KM; Bulman DE; Sadikovic B
Sci Rep; 2016 Dec; 6():38803. PubMed ID: 27934915
[TBL] [Abstract][Full Text] [Related]
16. 19q13.32 microdeletion syndrome: three new cases.
Castillo A; Kramer N; Schwartz CE; Miles JH; DuPont BR; Rosenfeld JA; Graham JM
Eur J Med Genet; 2014; 57(11-12):654-8. PubMed ID: 25230004
[TBL] [Abstract][Full Text] [Related]
17. Variable phenotype in 17q12 microdeletions: clinical and molecular characterization of a new case.
Palumbo P; Antona V; Palumbo O; Piccione M; Nardello R; Fontana A; Carella M; Corsello G
Gene; 2014 Apr; 538(2):373-8. PubMed ID: 24487052
[TBL] [Abstract][Full Text] [Related]
18. A novel microdeletion syndrome at 9q21.13 characterised by mental retardation, speech delay, epilepsy and characteristic facial features.
Boudry-Labis E; Demeer B; Le Caignec C; Isidor B; Mathieu-Dramard M; Plessis G; George AM; Taylor J; Aftimos S; Wiemer-Kruel A; Kohlhase J; Annerén G; Firth H; Simonic I; Vermeesch J; Thuresson AC; Copin H; Love DR; Andrieux J
Eur J Med Genet; 2013 Mar; 56(3):163-70. PubMed ID: 23279911
[TBL] [Abstract][Full Text] [Related]
19. [16p11.2 Microdeletion: first report in Argentina].
Tardivo A; Masotto B; Espeche L; Solari AP; Nevado J; Rozental S
Arch Argent Pediatr; 2017 Dec; 115(6):e449-e453. PubMed ID: 29087133
[TBL] [Abstract][Full Text] [Related]
20. Missense variant in SRCAP with distinct DNA methylation signature associated with non-FLHS SRCAP-related neurodevelopmental disorder.
White-Brown A; Choufani S; ; Weksberg R; Dyment D
Am J Med Genet A; 2023 Oct; 191(10):2640-2646. PubMed ID: 37340855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
